Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives

Abstract Background Oxidative stress may be involved in the pathophysiology of bipolar disorder (BD). Malondialdehyde (MDA), a product of fatty acid peroxidation has been proposed as a trait marker of BD associated with familial risk. However, little is known about MDA levels in young patients newly...

Full description

Saved in:
Bibliographic Details
Main Authors: Sharleny Stanislaus, Klara Coello, Hanne Lie Kjaerstad, Kimie Stefanie Ormstrup Sletved, Kamilla Woznica Miskowiak, Maria Faurholt-Jepsen, Klaus Munkholm, Henrik Enghusen Poulsen, Maj Vinberg, Jens Lykkesfeldt, Lars V. Kessing
Format: Article
Language:English
Published: SpringerOpen 2025-03-01
Series:International Journal of Bipolar Disorders
Subjects:
Online Access:https://doi.org/10.1186/s40345-025-00377-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850040108415188992
author Sharleny Stanislaus
Klara Coello
Hanne Lie Kjaerstad
Kimie Stefanie Ormstrup Sletved
Kamilla Woznica Miskowiak
Maria Faurholt-Jepsen
Klaus Munkholm
Henrik Enghusen Poulsen
Maj Vinberg
Jens Lykkesfeldt
Lars V. Kessing
author_facet Sharleny Stanislaus
Klara Coello
Hanne Lie Kjaerstad
Kimie Stefanie Ormstrup Sletved
Kamilla Woznica Miskowiak
Maria Faurholt-Jepsen
Klaus Munkholm
Henrik Enghusen Poulsen
Maj Vinberg
Jens Lykkesfeldt
Lars V. Kessing
author_sort Sharleny Stanislaus
collection DOAJ
description Abstract Background Oxidative stress may be involved in the pathophysiology of bipolar disorder (BD). Malondialdehyde (MDA), a product of fatty acid peroxidation has been proposed as a trait marker of BD associated with familial risk. However, little is known about MDA levels in young patients newly diagnosed with BD and their unaffected first-degree relatives (UR). Methods In this substudy of the ongoing longitudinal “Bipolar Illness Onset study”, we included baseline data and first, we compared fasting blood MDA levels in 130 young patients aged 15–25 years newly diagnosed with BD, 57 UR, and 88 healthy control individuals (HC). Second, we investigated associations between levels of MDA and illness variables in patients with BD. Third, we investigated associations between MDA levels and nucleoside damage by oxidation measured in urine. Fasting MDA levels from blood samples were measured using high-performance liquid chromatography (HPLC). Results In linear mixed effect models, adjusted for age and sex, MDA levels did not differ between patients with BD, UR, and HC, respectively. In patients with BD, we found no associations between levels of MDA and duration of illness, number of affective phases, illness onset or oxidatively damaged RNA and DNA. Conclusion Against expectations, MDA levels did not differ between young patients with BD, UR, and HC, thus, our findings did not support MDA being a state or a trait marker of BD associated with familial risk.
format Article
id doaj-art-ee618bf94a524299a7cb95bf5165d2ad
institution DOAJ
issn 2194-7511
language English
publishDate 2025-03-01
publisher SpringerOpen
record_format Article
series International Journal of Bipolar Disorders
spelling doaj-art-ee618bf94a524299a7cb95bf5165d2ad2025-08-20T02:56:10ZengSpringerOpenInternational Journal of Bipolar Disorders2194-75112025-03-0113111110.1186/s40345-025-00377-8Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relativesSharleny Stanislaus0Klara Coello1Hanne Lie Kjaerstad2Kimie Stefanie Ormstrup Sletved3Kamilla Woznica Miskowiak4Maria Faurholt-Jepsen5Klaus Munkholm6Henrik Enghusen Poulsen7Maj Vinberg8Jens Lykkesfeldt9Lars V. Kessing10Copenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center CopenhagenCopenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center CopenhagenCopenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center CopenhagenCopenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center CopenhagenCopenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center CopenhagenCopenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center CopenhagenCopenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center CopenhagenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of CopenhagenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of CopenhagenDepartment of Veterinary and Animal SciencesCopenhagen Affective Disorders Research Centre (CADIC), Psychiatric Center CopenhagenAbstract Background Oxidative stress may be involved in the pathophysiology of bipolar disorder (BD). Malondialdehyde (MDA), a product of fatty acid peroxidation has been proposed as a trait marker of BD associated with familial risk. However, little is known about MDA levels in young patients newly diagnosed with BD and their unaffected first-degree relatives (UR). Methods In this substudy of the ongoing longitudinal “Bipolar Illness Onset study”, we included baseline data and first, we compared fasting blood MDA levels in 130 young patients aged 15–25 years newly diagnosed with BD, 57 UR, and 88 healthy control individuals (HC). Second, we investigated associations between levels of MDA and illness variables in patients with BD. Third, we investigated associations between MDA levels and nucleoside damage by oxidation measured in urine. Fasting MDA levels from blood samples were measured using high-performance liquid chromatography (HPLC). Results In linear mixed effect models, adjusted for age and sex, MDA levels did not differ between patients with BD, UR, and HC, respectively. In patients with BD, we found no associations between levels of MDA and duration of illness, number of affective phases, illness onset or oxidatively damaged RNA and DNA. Conclusion Against expectations, MDA levels did not differ between young patients with BD, UR, and HC, thus, our findings did not support MDA being a state or a trait marker of BD associated with familial risk.https://doi.org/10.1186/s40345-025-00377-8Bipolar disordersLipid oxidationMalondialdehydeHigh-riskAdolescence
spellingShingle Sharleny Stanislaus
Klara Coello
Hanne Lie Kjaerstad
Kimie Stefanie Ormstrup Sletved
Kamilla Woznica Miskowiak
Maria Faurholt-Jepsen
Klaus Munkholm
Henrik Enghusen Poulsen
Maj Vinberg
Jens Lykkesfeldt
Lars V. Kessing
Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives
International Journal of Bipolar Disorders
Bipolar disorders
Lipid oxidation
Malondialdehyde
High-risk
Adolescence
title Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives
title_full Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives
title_fullStr Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives
title_full_unstemmed Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives
title_short Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives
title_sort lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives
topic Bipolar disorders
Lipid oxidation
Malondialdehyde
High-risk
Adolescence
url https://doi.org/10.1186/s40345-025-00377-8
work_keys_str_mv AT sharlenystanislaus lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT klaracoello lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT hanneliekjaerstad lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT kimiestefanieormstrupsletved lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT kamillawoznicamiskowiak lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT mariafaurholtjepsen lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT klausmunkholm lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT henrikenghusenpoulsen lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT majvinberg lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT jenslykkesfeldt lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives
AT larsvkessing lipidoxidationinyoungpatientswithnewlydiagnosedbipolardisorderandtheirrelatives